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Editorial
Population Health and Health Reform - Inseparable Concepts
By David B. Nash, MD, MBA
Editor-in-Chief

As dean of one of the nation’s leading
schools of population health, I would be
remiss if I didn’t devote special attention to
this critically important concept.
With 45% of us suffering from at least
1 chronic condition1 and more than 49
million of us lacking health insurance,2
the need for a population health approach
in the United States has never been more
urgent. Without exaggeration, the scope
of today’s population health challenge
is unprecedented, particularly when it
is coupled with the unrelenting upward
spiral of health care costs and the declining
health status of the general population (as
compared with previous generations).
Whatever shape it may take eventually,
population health will be essential to
the success of health care reform. Why?
Because it takes aim at the some of the
very basic shortcomings in our traditional
health care delivery system: namely,
enhancing health and wellness through
prevention and lifestyle changes, reducing
or eliminating waste and error, eradicating
disparities, improving transparency
and accountability, and improving care
coordination – a goal shared with health
care reform.

Population health looks beyond public
health at “the distribution of health
outcomes within a population, the health
determinants that influence distribution,
and the policies and interventions that
impact those determinants.”3,4 It spans
wellness and health promotion, chronic
disease management, care of the frail
and elderly, and palliative and end-of-life
care. In essence, broad population health
approaches are designed to preserve
wellness and minimize the physical and
financial impact of illness.
How does the Patient Protection and
Affordable Care Act (ACA) incorporate
the principles of population health? First
and foremost, it creates a new framework
for health care delivery in the United
States by adopting a comprehensive
national strategy for quality improvement,
the focus of which is clinically integrated
Prescriptions for Excellence in Health
Care is brought to Health Policy
Newsletter readers by Jefferson School
of Population Health in partnership
with Lilly USA, LLC to provide
essential information from the quality
improvement and patient safety arenas.
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systems-based practice. This should
result in care that is coordinated across
all diseases, providers, and care settings
over time. Importantly, hospitals and
health systems will be required to extend
their quality oversight processes as they
pursue collaborative relationships with
physicians and other entities.
The Accountable Care Organization
(ACO) program, a prominent feature
of the ACA, will have a major influence
on extending quality oversight processes
to outpatient settings,5 which is where
Americans receive the overwhelming
majority of their health care services.
A shared savings model, the ACO will
require participating providers to use the
tools of population-based care to achieve
the cost savings necessary for success.
The patient-centered medical home and
ACO models that feature prominently
in health reform contain aspects of care
delivery that fall under the umbrella
of population health. These efforts
and related new payment models are
an attempt to identify and eliminate
waste and inefficiencies in the system.
Today, much of the emphasis of health
reform is on these new payment models
that seek to improve quality and costeffectiveness in the system. However, for
true success in this environment, explicit

new methods for delivering care must
be part of the overall plan. Rather than
simply following the rules of reform,
health care leaders must fully understand
and follow the intricately related tenets
of population-based care as these will
have a major influence.
At this point, I’ll segue to a brief
overview of the articles featured in
this issue of our series on how various
provisions of the ACA have begun to
affect health care quality and population
health. This issue delves into 3
important areas:
“Accountable Care: Will it Transform
Health Care Delivery?” takes us through
the concepts, competencies, regulatory
constraints, and challenges associated
with the deployment of ACOs. The
author observes that it won’t be a
cakewalk, but there are opportunities
for success.
“Health Care Payment Reform: A Look
Ahead” takes a hard look at the issues
related to, and the likely impact of, new
payment models for health care delivery.
The final article, “Rethinking Health
Information Technology on the Journey
to Personalized Medicine,” reflects
on how secondary use of existing

health information can hasten the
development of more individualized
care - an exciting prospect!
I hope that this issue will serve to
enlighten and provoke discussion
around the linked concepts of health
reform and population health. As
always, I welcome questions and
comments from our readers. I can be
reached at: david.nash@jefferson.edu.
David B. Nash, MD, MBA, is the Dean
and the Dr. Raymond C. and Doris N.
Grandon Professor of Health Policy at
the Jefferson School of Population Health
(JSPH) of Thomas Jefferson University
in Philadelphia, PA.
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A Message from Lilly
The Opportunity to Create Policy Insights via the Implementation of the Patient
Protection and Affordable Care Act (ACA)
By Karen L. Friss, BS, MBA
By now the public may know the
Supreme Court ruling on key aspects
of the ACA: the individual mandate,
severability of the mandate from
some or the entire 2700-page law,
and Medicaid expansion.

The individual mandate requires
that all citizens (not currently
enrolled in a public health program)
purchase health insurance. Various
models have been created to forecast
the impact of a court decision

invalidating the individual mandate
while maintaining the other
components of the ACA. These
forecasts range from an exponential
increase to a significant reduction in
persons seeking insurance.
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I f the entire law is struck down,
Congress may act quickly to
reinstate some of the provisions that
generate revenue or are valued by
the public, or gridlock may continue.
This debate will play out alongside
presidential and congressional
elections in November. Everything
could look completely different
politically in 2013.
So, although the future of health
care for the current uninsured is
uncertain, it is a fact that ACA
implementation is under way. This is
evident on many levels:
• Over 2.5 million young adults
have enrolled in their parents’
insurance plans.
• 129 million Americans have
gained coverage as a result of
the elimination of preexisting
condition restrictions.
• Demonstration projects have
been initiated to improve care
and reduce costs in Medicare
and Medicaid.
• The federal government has
received revenue from the private
sector in various ways.
Significantly, many states have
already begun to evaluate and

prepare to implement state-based
insurance exchanges – a more
organized and competitive market
for buying health insurance. As
of March 2012, thirteen states
plus the District of Columbia had
legislatively established state-based
exchanges while 3 more states have
announced their intent to create
these entities.1 For those states
that move forward with exchange
implementation (regardless of the
Supreme Court decision), the health
policy field will benefit from very
public case studies.
The exchanges will be organized at
the state level while incorporating a
federally defined basic level of care
(the Essential Health Benefits). Per
the ACA, the state exchanges must
address 10 service categories2 but their
average standard of care is driven
by local standards (based on small
and large employer plans, Medicaid
plans, and the federal employee health
benefits program). And, the insurance
providers in each state will have to
propose plans that relate actuarially
to that average standard of care.
More information is available online
at: http://cciio.cms.gov/resources/
regulations/index.html#hie.
Watching these state implementations
raises interesting policy questions
that today’s scholars might want to
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consider. Here are a few and I suspect
you can think of more:
• Can the states tailor care standards
to their specific populations and
achieve better outcomes because
of variability between state plans?
• What state model of basic services
provides the best outcomes for
the overall population as well as
specific patient populations?
• Do exchanges work without
federal subsidies (if the Court
strikes down the ACA) or
can state-level oversight drive
improvements in quality and
reductions in cost more rapidly
and effectively than the federal
government (if the Court
upholds the ACA)?
Karen L. Friss, BS, MBA is Senior
Director, Global Public Policy at Eli
Lilly and Company.
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Accountable Care: Will it Transform Health Care Delivery?
By Allan B. Goldstein, MD, MPH
What is an Accountable Care Organization?
The Patient Protection and Affordable
Care Act describes an Accountable
Care Organization (ACO) as a group

of providers of services and suppliers
“willing to become accountable for the
quality, cost, and overall care of the
Medicare beneficiaries assigned to it.”

Additional characteristics of the ACO
include a formal legal structure with
shared governance; appropriate
(continued on page 4)
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leadership and management structure;
processes to promote evidence-based
medicine, patient engagement, and
care coordination; mechanisms to
report on quality, patient experience,
and cost measures; and creation of an
environment of patient-centeredness.1
Although other ACO definitions and
descriptions have been formulated,
the common denominator is that
provider groups working together will
be accountable for a defined population
and employ measurable outcomes as
criteria.2 The accountable care model
takes many of the disparate threads of
health care reform and weaves them
into an integrated fabric. From another
perspective, accountable care may be
viewed as a health care delivery model
that optimally employs standardized
processes and tools, measurement, and
information-driven improvement to
achieve its goals. Because a broad range of
delivery systems meet these requirements,
the ACO structure allows for both
flexibility and diversity in delivery system
design as we learn more about this model
and refine it based on experience.
Key Organizational Competencies
Organizations may need a tool to
help them understand what it means
to be an ACO, as well as to evaluate
the status of their current operational
capabilities and to identify the gaps they
must fill to qualify as an ACO. One
such benchmarking tool, developed
by Premier Inc., has established 6
key organizational competencies
required to perform the functions of
an ACO (Premier Accountable Care
Organization Capabilities Framework
Assessment Tool, unpublished data,
2011). These core competencies are
shown in Figure 1.
Each component is divided into
Capabilities and subdivided into

Operating Activities, each of which
constitutes a discrete core competency
the organization must develop to
become an ACO. With more than
150 operating activities (Premier
Accountable Care Organization
Capabilities Framework Assessment
Tool, unpublished data, 2011), the task
of organizational transformation to an
ACO will be a prodigious undertaking.
Figure 1 provides a visual
representation of the relationships
among these key components as
interpreted by Premier’s Accountable
Care Collaborative.
Regulatory Constraints
On March 31, 2011, the Centers
for Medicare and Medicaid Services
(CMS) published proposed rules for
Medicare contracting with ACOs.3
Following receipt of extensive feedback
from a broad range of stakeholders
regarding the regulatory constraints
imposed by the proposed rules, CMS
published final rules governing the
implementation of the Medicare
Shared Savings Program (MSSP) on
November 2, 2011.4 Four requirements
in the final rules represent significant
obstacles to provider entities that are
considering creating ACOs to serve
the Medicare population.
First, CMS acknowledged that
provisions of the Physician
Self-Referral Law, the Federal
antikickback statute, and the civil
monetary penalties law “may impede
development of some of the innovative
integrated-care models envisioned
by the” MSSP.5 In conjunction with
the Office of the Inspector General,
CMS established 5 unique waiver
requirements covering a variety of
arrangements that ACOs might need
to undertake in order to be successful
at carrying out the MSSP.6

Figure 1. The Accountable Care Organization:
Conceptual Architecture

Core Components:
• People-Centered Foundation
• Health Home
• High-Value Network
• Population Health Data Management
• ACO Leadership
• Payor Partnerships
© 2010 Premier, Inc. Used With Permission.

The Internal Revenue Service has
provided guidance for 501(c)(3) notfor-profit corporations that participate
in the MSSP through an ACO,
enumerating those circumstances
under which the not-for-profit entity
could avoid impermissible inurement
or private benefit that would adversely
impact its status.7 Organizations
forming ACOs also must satisfy
state anticompetitive rules. Creating
a legal and governance structure
that conforms to all the regulatory
requirements will be a challenging
early step for prospective ACOs.
Second, beneficiary assignment for
the MSSP will be retrospective based
on the “plurality of their primary care
services during the performance year.”8
CMS acknowledges the challenges
this creates for the prospective ACO
that must develop and implement a
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population management strategy for a
population that is defined after the fact.
Third, in response to extensive
comments and criticism of the proposed
quality reporting requirements, the
final rule requires ACOs to report on
33 quality measures (instead of 65)
spanning 4 quality domains (patient/
caregiver experience of care, care
coordination/patient safety, preventive
health, and at-risk populations).8
Although this reduction in the number
of reportable quality measures (and
employment of nationally endorsed
measures already in use) mitigates
the magnitude of the data collection
and reporting requirement for ACOs,
33 measures represent a significant
administrative burden for most
organizations. In addition, there is
concern that ACOs will manage to the
metrics rather than focusing on other
meaningful process improvements that
may not impact the metrics.
Fourth, ACO receipt of shared
savings is subject to meeting quality
performance targets and exceeding a
minimum savings rate of 2.0%-3.9%
below the applicable benchmark. The
ACO will be eligible for a maximum
shared savings rate of 50% (1-sided
model) or 60% (2-sided model).
Calculation of benchmarks and actual
payments from CMS will be subject to
a variety of adjustments that may make
cash flow projections difficult.9
Organizations will be required to make
substantial up-front investments to
create the requisite ACO infrastructure.
However, it may be several years before
the ACO generates savings and it remains
unclear if the savings realized will be
adequate to repay the initial investment,
motivate behavior change by providers, or
create a sustainable business model.

Critical Challenges to Accountable Care
Deployment
In many localities, the hospital is the
only care delivery entity with the
organizational and financial resources
to develop an ACO. Hospitals have
been acquiring primary care and select
specialty practices at an accelerated rate
over the last several years. Collaborations
between hospitals and physicians have
a troubled history marked by mistrust
and competition for lucrative services.10
Converting physicians to hospital/health
system employees does not obviate the
need to align physicians’ goals with those
of their new employers and to make
necessary attitudinal and behavioral
changes. Many physicians may fear their
loss of autonomy, and resist efforts to
standardize care delivery processes and
measure performance against objective
metrics. Overcoming such resistance will
be essential to ACO success.
Establishing the infrastructure necessary
to support an accountable care delivery
system will require considerable capital
investment. CMS has estimated the
initial ACO development investment at
$1.8 million, but the American Hospital
Association estimates that $5.3 to $12.0
million will be needed, depending on
system size and complexity.11 These
figures do not include the ongoing cost
of ACO operations, which is estimated
at $6.3 to $14.1 million annually. These
costs will be incurred regardless of the
ACO’s success or its ability to earn
shared savings. Despite such substantial
investment, organizations have no
guarantee that there will be a return
on investment or that accountable care
represents a sustainable, long-term
business model.
Accountable care will challenge the basic
tenets of today’s health care system.
Although providers are currently paid
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on a piecework basis, they can expect
numerous efforts to foster alternative
payment mechanisms. Long viewed as a
major revenue generator for the delivery
system, the hospital will become a cost
center, as will all other care delivery
settings. Hospitals will become the focus
of intense efforts to eliminate waste and
duplication with the goal of maximizing
system efficiency and value.
Transforming to an accountable delivery
system will not occur at a fixed point
in time. Rather, it will occur over an as
yet undetermined span of time. During
this transition phase, providers will be
operating in a care delivery environment
with a split personality. Managing
through that transition will be one of the
most difficult challenges for future ACOs.
Opportunities for Early Success
The Health Home represents a major
innovative advance in primary care and is
a foundational prerequisite for a successful
ACO. Despite significant energy and
resources currently dedicated to Health
Home deployment, these transformed
practices still represent a small fraction of
the primary care delivery system. ACO
deployment can facilitate and support the
rapid expansion and adoption of Health
Homes, resulting in higher quality,
patient-centered care. Embedding case
management services within the Health
Home and concentrating efforts on the
sickest patients will improve coordination
of patient services and reduce costs.12 In
addition, coordinating care transitions can
dramatically reduce hospital readmissions.
A corollary to ACO implementation is
the commitment to make clinical quality
improvement part of the organization’s
core business strategy. Reduction of
unwanted variation in physicians’ practices
is an excellent place to begin these efforts.
By selecting high-volume, high-cost
(continued on page 6)
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treatments and focusing on care delivery
processes, the organization can embed
evidence-based clinical practice guidelines
into the flow of clinical activities. With
20 years of experience using this model,
Intermountain Healthcare estimates that
it can reduce clinical costs by 6%-10%
while improving clinical outcomes.13 Once
physicians are provided with relevant,
actionable information and see the impact
of process improvement activities, they
will drive most of the changes themselves.
Process improvement has been shown to
reduce the frequency of adverse events
and avoidable deaths in the hospital.14
Potential Downstream Consequences of
Adopting Accountable Care
Many changes will occur in the health
care landscape over the next 10 years.
The adoption of ACOs is expected
to accelerate the pace at which these
changes take place.
In the future, US health care will be
dominated by competing, vertically
integrated delivery systems comprising
a diverse group of provider stakeholders
and, potentially, insurers. The integrated
delivery system will be a risk-taking
entity accountable for a defined
population of patients. Customer service
will be a foundational element of the
delivery system and critical to its success.
System performance will be measured
using broadly accepted cost, quality, and
patient experience metrics.

The Health Home will be the system
point of entry and the center for care
delivery and coordination. Disease and
case management services will emanate
from the Health Home. Primary care
practices will be larger and linked into
self-managing networks. Non-affiliated
solo and small group practices will not
be financially viable business options.
An increasing percentage of patient
encounters will be provided by e-visits,
group visits, and in the home setting.
Reimbursement systems that align
incentives and reward performance
will predominate. Fee-for-service
reimbursement will be the exception
rather than the norm.

if ACOs fail to meet the challenge,
other economic, demographic, and
governmental forces will step in. In any
event, transformation of the American
health care delivery system is inevitable.
Allan B. Goldstein, MD, MPH, is the
Founder and Principal, Goldstein Health
Care Consulting, LLC. He can be reached
at: allanbg626@gmail.com.
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Health Care Payment Reform: A Look Ahead
By Cary Sennett, MD, PhD
The public debate about raising the
federal debt limit—and Standard and
Poor’s downgrading the rating of federal
bonds—have contributed to a growing
consensus that controlling federal
spending should be an urgent national

priority. Controlling federal spending on
health care must be a central part of that.
Figure 1 lays out the issue visually: the
Congressional Budget Office projections
for federal spending (as a percentage of

gross domestic product) show inexorable
growth to levels that are clearly
unacceptable. But, when the spending
is broken down into its components,
we see that the projected growth is
driven entirely by outlays for health
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care; specifically Medicare, Medicaid,
the state Children’s Health Insurance
Program, and projected subsidies for the
Health Insurance Exchanges created by
the Affordable Care Act (ACA). The
problem of rising health care costs is not
merely a threat to health care; it is a very
real threat to the sustainability of the
American economy.
Long-term control of health care
costs—or, more desirably, long-term
improvements in the value of health
care—will require fundamental reform of
our health care system and, in particular,
fundamental change in the organization
and operation of health care delivery
systems across the country. Given the
indispensable role of physicians in
delivering health care and shaping the
processes through which it is delivered,
it is inconceivable that necessary changes
can take place without the active and
willing participation of those who
practice medicine. And therein lies the
concern; many physicians are neither
active nor willing partners in effecting the
process changes that must accompany
health care reform.

Health care reform is seen by some as a
threat to physician income. The new law
is, after all, the Patient Protection and
Affordable Care Act, and affordability can
translate into pressure on the incomes
of all health care providers. More often
though, health care reform is equated with
accountability; indeed, many people think
that “ACA” stands for the Accountable
Care Act. For physicians, accountability
has come to mean public reporting,
compliance, and the considerable costs
associated with them. It should come as
no surprise that, as they are understood by
physicians, affordability and accountability
offer little to make health care reform an
appealing and attractive proposition.
Solving the Problem: The Central Role of
Payment Reform
Although improving the value of health
care will require movement on several
fronts, new ways of paying for care are
likely to be central to efforts. Clearly,
delivery system reconfiguration is the
“end game” but, as Donald M. Berwick,
MD put it, “Every system is perfectly
designed to achieve exactly the results it
gets.”1 Fee-for-service (FFS) payment for

Figure 1. Actual and projected federal outlays as a percentage of Gross Domestic
Product (GDP).

Source: CBO’s 2011 Long-Term Budget Outlook. Washington, DC: Congressional Budget Office; June 22, 2011.
CBO=Congressional Budget Office, CHIP=Children’s Health Insurance Program
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health care services drives service volume
and intensity. If we want a delivery system
that drives value, we must change the way
we pay for health care.
If there is any good news, it is that
the political will to take on the issue
of payment reform appears to have
reached a tipping point. On one hand,
the budgetary issues that have driven
federal debt have intensified pressure to
act. On the other hand, there is growing
acceptance of the premise that the current
formula for Medicare adjustments to
physician payments—the “Sustainable
Growth Rate”—is not “fixable” and
that some other methodology must
replace it. In fact, the Medicare Payment
Advisory Commission has issued
recommendations to move away “from
the Sustainable Growth Rate System,”
to “shift Medicare payment policies
away from FFS,” and to “make FFS
less attractive.”2
There are several alternatives that
could “shift Medicare payment policies
away from FFS”—alternatives that
vary substantially with respect to the
performance risk they create for providers.
At one end of the risk spectrum is
“salary.” Salaried physicians have income
predictability, but very little upside (and
virtually no downside) risk to that income.
At the other end of the spectrum are
“bundled” or “episode-based” payments,
and global or “population-based”
payments. Under these systems, physician
income may have considerable upside
potential but there often is considerable
downside risk. Figure 2 is a brief, highlevel summary of alternative payment
strategies plotted along a risk continuum.
Of course, variation is possible in each of
these payment themes and the strategies
for combining them.
Which strategy/strategies are “best”
for achieving the optimal results? The
(continued on page 8)
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evidence is still accumulating. It seems
likely, though, that almost any strategy
can work in some settings—and that
almost none can work in all settings. So,
the challenge will be to understand what
type of payment model works best in a
particular context or setting.
Physicians and Financial Risk
Given the importance of risk as a
motivator of change—and the variation
in risk implicit in different payment
models—it is necessary to consider how
physicians respond to risk. Historically,
physicians have not managed risk well,
and many have been inclined to avoid
it to the extent possible. At the limit,
avoiding risk is best achieved through
salaried employment, and we have seen
more and more physicians embracing that
model. But there are strategies to mitigate
risk as opposed to avoiding it completely.
One such strategy is affiliating with an
entity that is better prepared to accept
and to manage risk. Physicians and
medical groups are motivated to affiliate
with larger, better capitalized (hence
more risk-tolerant) organizations such as
integrated delivery systems, physicianhospital organizations, and larger
medical groups or Independent Practice
Associations, which function as large,
virtual medical groups. As part of these
larger entities, physicians are insulated
from some of the risk that attends more
advanced payment models.
At the other end of the spectrum, some
physicians and medical groups have
prepared (or are preparing) themselves
to understand and accept financial risk,
and are seeking to be paid in ways that
offer significant upside opportunity. To
manage risk, these groups had to acquire
new actuarial and care management
skills and invest in the information,
knowledge, and care management
infrastructure required to understand
and respond to clinical risk. These

Figure 2. Payment Strategies as a function of Provider Risk

FFS=fee for service, PCMH=patient-centered medical home

investments require size and scale as well
as considerable capital.
Where Are We Headed?
We are in the early stages of a period of
rapid change. The specific shape of that
change is difficult to predict and, almost
certainly, the course will be one marked
by frequent correction. That said, I
believe that there are certain givens or, at
the very least, likely outcomes:
- There will be progressive expansion of
the number and intensity of risk-based
payment options
We are already seeing some
experimentation, and I expect that
promising models for replacing FFS
will be scaled rapidly. Much of the
experimentation is occurring in the
private sector where pressure for change
is intense, but regulatory constraints
on innovation may be less binding.
It is very important to note that the
Center for Medicare and Medicaid
Innovation (“the Innovation Center”
at the Centers for Medicare and
Medicaid Services [CMS]) has recently
announced a Bundled Payment for
Care Improvement initiative,3 which
complements CMS’s Acute Care
Episode demonstration.4 Together, and
with the construction of a Medicarespecific Episode Grouper (Section 3003
of the ACA requires that the Secretary
develop a Medicare-specific episode
grouper by January 1, 2012),5 these

strategies suggest that Medicare may
be able – and inclined - to introduce
bundled payments into the mainstream
of Medicare in the foreseeable future.
- Vertical integration in health care will
continue…
Although the response to the Medicare
Shared Savings Program (MSSP)
may be limited, the marketplace
clearly understands the inevitability of
“accountable care,” and is responding
in a variety of ways to create entities
that are better able to coordinate care
and manage risk. Although these
responses are quite pleomorphic, many
appear to be steps on a path toward
structural integration: in particular,
“clinical integration” achieved through
the acquisition of physician practices
by hospitals.
…but there will be more and more
virtual integration
Structural integration is a vehicle to
accomplish the coordination of care
necessary to achieve better clinical and
financial outcomes; however, it is only one
way in which hospitals, physicians, and
other providers can achieve those ends.
Although they offer certain advantages,
it is important to note that truly
integrated systems (eg, Geisinger) are not
built quickly and more nimble, virtual
structures are likely to continue to emerge.
Some of the models being developed in
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the private sector6 may be in response to
the MSSP, and to the Innovation Center’s
Bundled Payment Initiative.
- There will be many bumps in the road
Although there is a path forward,
the direction is clearer than the
topography. At a time when there
is intense pressure to respond, there
will be some missteps. “Nimbleness”
will be a critical success factor.
One of the central challenges that
will need to be addressed—and one
that can be anticipated and managed
affirmatively—is potential resistance
among practicing physicians. Physician
resistance to change in payment and
delivery system organization will, at a
minimum, create inertia and friction.
At the limit, they could cause gridlock.
Physician resistance is not inevitable
but, for the reasons outlined earlier, is
probable. In general, health care reform
represents a threat to physicians who may
perceive the cornerstones of reform—
“affordability” and “accountability”—as
forces that exert pressure on their
income and autonomy. A recent survey
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by the Massachusetts Medical Society
suggests that the majority of physicians,
for example, would not participate in a
voluntary bundled payment program,
and only about half would participate
in a voluntary Accountable Care
Organization.7 At the same time, many
physicians are dissatisfied with the
current health care system, and many
would welcome change if that change
would allow them to practice medicine as
the professionals they are.

For success under the new set of rules
that will guide the transformation, we
must ensure that physicians are equipped
with the knowledge and tools they need.

So, among the critical requirements for
making the necessary changes in the
payment and delivery systems are:

2. Boccuti C, Hayes K, Bloniarz K. Moving forward from
the sustainable growth rate system. http://medpac.gov/
transcripts/SGR%20sept%202011%20handout.pdf.
Accessed September 19, 2011.

1. An understanding of what
physicians perceive as a better way
to deliver care, and
2. Recognition that the tools and
additional supports needed by
physicians to reconfigure their
practices must be made available in
parallel with – or in advance of the policy changes that will force
the reconfiguration.
Transforming health care means
changing the way physicians practice.

Cary Sennett, MD, PhD is the President of
IMPAQ International. He can be reached
at: [csennett@impaqint.com].
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Rethinking Health Information Technology on the Journey to Personalized Medicine
By Brett J. Davis
Health care and life sciences
organizations have long recognized
the potential for a convergence of
their 2 disciplines, envisioning a
bidirectional information pipeline
between bench and bedside that
would facilitate the development
of more personalized and effective
treatments. For several years, the
health care community has struggled
to make progress on this front in
the face of multiple challenges that

range from institutional objections to
change, to security/privacy concerns,
to inadequate funding, to technology
limitations.
With global health systems under
unprecedented strain, the realization of
personalized medicine has never been
more imperative – and, in the wake of
breakthroughs in our understanding
of biology at the molecular level, it has
never been more possible.

Although the health care industry is
poised for progress, a significant hurdle
remains: Building the right information
technology (IT) infrastructure to support
the new data management challenges of
this paradigm. Many IT systems being
adopted across research and care domains
today were not designed to permit the
secondary data uses that are necessary for
research and personalized care. To a great
extent, these existing transactional systems
(continued on page 10)
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support individual silos across the health
science ecosystem that impede - and in
many cases prevent - the integrated view
of data that is essential for collaborative
research activities including management
of genotypic and phenotypic data,
analytical secondary uses of health
data, and the ultimate realization of
personalized medicine.
To move forward, health sciences
organizations must take a different
approach to their health care IT
infrastructures – an approach that
enables large-scale reuse of the vast
volume of health care information that
is locked in today’s transactional systems.
New platforms will be required to enable
health care information exchange among
organizations. New analytic solutions will
be necessary to answer the most difficult
questions in health care: What works, for
whom, why, in what context, and at what
cost? The next generation of health care
IT systems has the potential to be truly
transformational and usher in a new era
of health care delivery but a critical first
step is recognizing that today’s systems
were not designed to get us there.
Industry at a Crossroad
Over the past 25 years, the world has
seen an unprecedented expansion of
scientific knowledge as a result of
breakthroughs in imaging, genomics,
proteomics, diagnostics, and other
disciplines. These breakthroughs promise
to deliver precision medicine for some
of the most complex and debilitating
diseases (eg, cancer, Alzheimer’s disease,
Parkinson’s disease) as well as prevalent
chronic conditions such as diabetes.
At the same time, global health systems
are nearing their breaking points. Like
other developed nations, the United
States is struggling with skyrocketing
costs associated with aging populations
and the management of increasingly
expensive chronic conditions. The

United States also must address the
serious issues of inconsistent quality and
outcomes that are not commensurate
with the dollars expended.
Even after accounting for variations in
wealth, the Organization for Economic
Cooperation and Development estimates
that approximately 31% of total US
health care expenditures are “excess” in
comparison with other member nations.1
In the United States alone, estimates of
the tab for unwarranted care range from
$250 billion to $325 billion annually.2
Another example of “wasted” care is that
many major classes of drugs do not work
for a large percent of the population who
take them each year. For example, 38% of
patients with depression, 50% of patients
with arthritis, 40% of patients with
asthma, and 43% of patients with diabetes
will not respond to initial treatment.3
Personalized medicine represents a
potential way forward. It can help
address cost and quality challenges
by promoting targeted therapies and
interventions for the patient populations
most likely to benefit from them. If built
using a data driven approach, it can
sustain and accelerate new discoveries
and innovations that advance prevention
or improve outcomes.
A Perfect Climate for Change
At a time when it is most needed, the
health care industry is experiencing a
convergence of developments that present
an opportunity to achieve substantial
progress on the path to personalized
medicine. Each of these developments
requires new information management
platforms beyond today’s clinical systems.
First, scientific advances in the last
decade are providing valuable insight
into the reasons why some patients
may be more susceptible to particular
conditions and/or respond differently to
specific treatments. With the completion

of the Human Genome Project, we
have entered an exciting new era that
is yielding a broader understanding of
health and disease at a molecular level.
We are realizing important benefits,
such as the ability to assess genetic risk
for certain types of cancer or to predict
which individuals may react positively
or negatively to a particular treatment.
Most experts expect the rapid pace of
advancement in scientific understanding
to continue for many years to come.
The second important trend is a
fundamental shift in the approach to
health care reimbursement. For example,
the United States has begun a transition
from its traditional fee-for-service model
to a pay-for-value approach that rewards
outcomes. The Patient Protection and
Affordable Care Act of 2010 (ACA)
will expand a number of programs that
were piloted by the Centers for Medicare
and Medicaid Services in the last
decade. Specifically, Medicare’s launch
of the Hospital Value-based Purchasing
Program in October 2012 will mark the
beginning of a fundamental shift in how
Medicare pays health care providers and
facilities. Under the new program, US
hospitals will be paid for inpatient acute
care services based on care quality - not
just the quantity of the services they
provide. Many private insurers are also
experimenting with new reimbursement
strategies that reward value and outcomes.
Finally, comparative effectiveness
research (CER) initiatives also factor
into the mix of activities that are likely
to reshape how health care organizations
treat patients. The ACA authorizes
the creation of a nonprofit corporation
known as the Patient-Centered
Outcomes Research Institute, the
purpose of which is to assist patients,
clinicians, purchasers, and policy makers
to make informed health decisions
through CER. The Institute supplants
the Federal Coordinating Council for
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Comparative Effectiveness Research,
established under the American
Recovery and Reinvestment Act of 2009,
which allocated $1.1 billion for CER.
A Fractured Frame
With the necessary scientific and
policy components in place to advance
personalized medicine, the industry
now must address the technological
barriers. To be effective, health care
organizations must reconfigure their
information infrastructures to enable
large-scale secondary use of the health
care data that is locked in their existing
transactional systems (Figure 1).
Secondary use of data captured in
transactional systems across the
health care ecosystem (eg, electronic
health records, claims/billing systems,
clinical trial management systems,
research databases, clinical and
laboratory systems) is essential to
enable and accelerate the new paradigm
of personalized health care. The
information-based transformation of
health care to a more personalized
health care paradigm is conceptualized
in the “learning health care framework”
first introduced in a 2007 Institute of
Medicine Study.
A majority of today’s health care IT
systems were created to automate specific
workflows (eg, research, back office,
direct care); hence, they are fragmented
from a data perspective. The secondary
use of data captured in core transactional
systems is required for analysis that
affords insight. In order to support a
rapid-learning, value-based, personalized
health care paradigm, data from these
source systems must be “freed” and
aggregated for secondary data usage.
For example, there are many financial,
supply chain, claims, and billing systems
that can determine costs within a health
care organization; however, these systems

cannot correlate these data with the actual
cost of treating a patient for a specific
condition or calculate the outcome of that
treatment. The initial goal of capturing
the data was to track a set of procedures
in order to bill a payer and/or patient for
the services rendered. In a value-based
reimbursement system, organizations
must be able to access, aggregate, and
analyze these data to correlate costs and
outcomes across patient populations.
The IT implications for this new
paradigm are significant, particularly
with respect to the need for secure
exchange of data between systems and
the analytics necessary to glean insights
from the secondary use of the data in
these systems.
Recognizing this need, the industry has
begun to make the investments necessary
to create interoperability between
transactional systems and analytics
platforms for the analysis of that data.
As stated previously, most transactional
IT systems adopted across the research
and care domains today were purpose
built (ie, not designed, developed, or
implemented with the requirements
of value-based personalized medicine
in mind). These systems fall short
on multiple fronts; most importantly,
their failure to collect the necessary
information in the right context and
their inability to provide the necessary
linkage between financial, operational,
research, and clinical data and processes.
Building a New Foundation
Value-based personalized medicine
requires the ability to manage, integrate,
analyze, and leverage clinical, financial,
claims, and other biomedical information
from across the health care enterprise
and from external sources.
Two fundamental technologies will
drive the transformation. The first is
an interoperable health information
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Figure 1. Multiple Applications of
Secondary Use of Health Care Data
Health Care Providers
Clinical quality initiatives and reporting
Operational efficiencies
Financial performance management
Pay-for-performance initiatives
Pharmaceutical / Biotechs
Comparative effectiveness
Adaptive trials to support personalized
medicine
Consumer and physician engagement and
decision support
Academic Medical Centers
Translational, clinical, and comparative
effectiveness research
Collaborative and extra-enterprise research
Public Health
Disease surveillance
Comparative effectiveness and clinical
utility studies
Adapted from Transforming Healthcare Through Secondary
Use of Health Data. PricewaterhouseCoopers (PCW); 2009.

exchange that will aggregate and
normalize data from core transactional
systems and enable health care providers
and researchers to act on it. In today’s
multi-vendor environments, integration
standards and repeatable processes
are critical to providing adequate data
management capabilities. Building the
right infrastructure to support data
collection, integration, and transformation
is essential to enabling new insights.
The second essential IT component,
enterprise analytics, will drive more
productive use of secondary health
data on a wide scale. In the business
bestseller, Competing on Analytics,
authors Tom Davenport and Jeanne
Harris make important distinctions
between capabilities that enable access
and reporting and those that provide
true analytical insights. Much of the
business intelligence industry has focused
on capabilities that enable reporting,
structured or ad hoc queries, and
(continued on page 12)
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alerts that make delivery of surfacing
information to decision makers more
efficient. Davenport and Harris
point out that the next level of value
will be through more predictive and
optimization-oriented solutions and
practices.4 Their careful analysis of
high-performing companies across
multiple industries found a substantial
correlation between the extensive use
of analytics among high performers
versus low performers.4
The same approach applies to the
business and delivery of health care as
well. Health care organizations require
retrospective and predictive analytics
that span enterprise data. Only then will
they acquire the necessary insight to
predict the likely outcome of a specific
course of treatment for a specific patient
in real time. With these tools, providers
also may be able to gain a better
understanding of the true cost of care
and more accurately predict important
outcomes such as the likelihood for
readmission, the precise treatment for
an individual’s genotype and phenotype,
or the risk of adverse events.
In the short term, the industry is
deploying various stopgap measures.
End users’ need to glean some insights
from existing transactional systems
is driving investment in expensive,
limited, one-off data marts and
analytics environments. This, in turn, is
generating more silos and complexity
in health systems’ IT environments.
Without exaggeration, this is a very
complex and thus expensive way to
approach analytics.
As health care organizations come
to realize the importance of analytics

systems, they are beginning to invest
in enterprise-class, interoperable
analytics platforms. This is true
for biopharmaceutical companies,
payers, and providers as well as
academic medical centers. Health
care organizations should think about
these investments in the context of
their trading partners. By investing in
more robust information management
architecture, organizations extend their
ability to share data with other partners.
In addition to leading to greater
innovation, such investments can create
new opportunities for collaboration.
A Platform Approach Accelerates Change
Historically, the process of creating
and implementing a data model,
building an enterprise data warehouse,
and creating customized analytical
applications has been a very expensive
and lengthy undertaking - one that
is beyond the resources of all but the
largest of health care organizations. In
essence, this approach requires health
care organizations to be software
development shops. An alternative
to this expensive, complex approach
is a platform-based approached to
analytics solutions. The move toward
a “productized” platform enables
enterprise analytical applications and
reduces costs and implementation
timelines, thereby making the
technology more accessible for health
sciences organizations of all sizes.
Conclusion
Secondary use of electronic health care
data can answer the hard questions in
health care: What works for whom,
why, in what context, and at what cost?
To enable secondary use of health
data and drive the advancement of

personalized medicine, health sciences
organizations require an integrated
view across disparate transactional
systems. This calls for a robust
enterprise model that is optimized for
analytics versus transactions. Once
such a model is in place, the use of
well-defined and well-integrated
analytics throughout the health care
value chain can be transformative.
Given the immense size of the
data challenge, the distinctness and
geographic spread of many health
care-related activities, and the fact
that so many health care activities are
conducted by different companies and
organizations that must interact with
each other, there is really no other way
to provide the tools necessary to enable
and deliver personalized medicine and
to control spiraling costs.
Brett Davis is Senior Director, Strategy
and Business Development, at Oracle
Health Sciences. He can be reached at:
brett.davis@oracle.com
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